Richard Lebowitz, MD
Otolaryngology · New York, NYNPI 1285653832
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.7%), education and consulting fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Metrex Research, LLC at 35.7% of the total. Reporting peaked in 2021 at $3,893 and has fallen 93.2% since, to $265 in 2025. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $132.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Metrex Research, LLC$3K
- Acclarent, Inc$2K
- Sanofi$2K
- Intersect ENT, Inc.$566
- Stryker$420
- Neurent Medical Limited$175
- plus $705 from 7 others
What the payments were for
- Consulting fees$1,30416%
- Food & beverage$4,07649%
- Education$2,99036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Metrex Research, LLC | 1 | $2,990 |
| Acclarent, Inc | 31 | $1,900 |
| Sanofi | 5 | $1,613 |
| Intersect ENT, Inc. | 5 | $566 |
| Stryker | 10 | $420 |
| Neurent Medical Limited | 1 | $175 |
| Optinose US, Inc. | 2 | $149 |
| Aerin Medical Inc. | 1 | $136 |
| Medtronic(2 entities) | 3 | $135 |
| Spirair, Inc. | 1 | $129 |
| Integra Lifesciences Corporation | 1 | $92 |
| Baxter Healthcare | 1 | $40 |
| GSK | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TruDi Nav Cable$561
- DUPIXENT$413
- PROPEL$399
- SeptAlign$258
- TURBALIGN$258
- NEUROMARK Device$175
- NEUROMARK Radiofrequency Console$175
- SINUVA$149
- VIVAER STYLUS$136
- RHINAER STYLUS$136
- Xhance$135
- Acclarent Aera$113
- CONSUMABLES$110
How this compares
$8,370 in reported general payments places this provider in the 90th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 15 | $1,810 |
| Ipratropium Bromide | 51 | $1,118 |
| Mupirocin | 33 | $461 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New York
- Roheen RaithathaNew York$830K
- Dennis KrausNew York$159K
- Anthony DelsignoreNew York$89K
- Satish GovindarajNew York$39K
- Lawrence LustigNew York$33K
- Justin GolubNew York$30K
- Brett MilesNew York$30K
- David HiltzikNew York$25K
- Milan AminNew York$23K
- Ashutosh KackerNew York$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.